{"id":26854,"date":"2025-12-19T10:55:35","date_gmt":"2025-12-19T09:55:35","guid":{"rendered":"https:\/\/dev8.id-interactive.fr\/new_unither\/a-novel-approach-to-dry-eye-disease-treatment\/"},"modified":"2026-02-03T15:52:26","modified_gmt":"2026-02-03T14:52:26","slug":"a-novel-approach-to-dry-eye-disease-treatment","status":"publish","type":"post","link":"https:\/\/dev8.id-interactive.fr\/new_unither\/a-novel-approach-to-dry-eye-disease-treatment\/","title":{"rendered":"A Novel Approach to Dry Eye Disease Treatment"},"content":{"rendered":"<p data-pm-slice=\"1 1 []\"><strong>Download the Whitepaper<\/strong><\/p>\n<h3 data-start=\"167\" data-end=\"214\">Discover a New Approach to Dry Eye Relief<img loading=\"lazy\" decoding=\"async\" class=\"wp-image-19788 size-medium alignright\" src=\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2025\/01\/caragelose-whitepaper-eye-drops-250x352.png\" alt=\"\" width=\"213\" height=\"300\" \/><\/h3>\n<p>Dry Eye Disease (DED) affects millions of people worldwide, often leading to discomfort, blurred vision, and reduced quality of life. If you&#8217;re looking for innovative, preservative-free solutions that go beyond traditional eye drops, this whitepaper could be of real value.<\/p>\n<p>This whitepaper presents an in-depth analysis of Carragelose\u00ae, a preservative-free ophthalmic solution designed to address the challenges associated with Dry Eye Disease (DED). With its unique mucoadhesive and hydrating properties, Carragelose\u00ae offers an alternative to conventional treatments by enhancing tear film stability and prolonging moisture retention.<\/p>\n<h4><span style=\"color: #4abdcf;\">Key Topics Covered:<\/span><\/h4>\n<ul data-spread=\"false\">\n<li>The molecular composition and mechanism of action of Carragelose\u00ae.<\/li>\n<li>Comparative in-vitro and clinical data demonstrating its efficacy.<\/li>\n<li>Insights into the role of mucoadhesion in ocular surface protection.<\/li>\n<li>A discussion on how it compares to traditional hyaluronic acid-based formulations.<\/li>\n<\/ul>\n<h3><strong>Access the Full Whitepaper<\/strong><\/h3>\n<p>Complete the form below to download the whitepaper and explore the latest advancements in Dry Eye Disease treatment.<\/p>\n<p><script charset=\"utf-8\" type=\"text\/javascript\" src=\"\/\/js-eu1.hsforms.net\/forms\/embed\/v2.js\"><\/script><br \/>\n<script>\n  hbspt.forms.create({\n    portalId: \"25445150\",\n    formId: \"0518e89e-5769-4700-ac8c-5e53a9ed6573\"\n  });\n<\/script><\/p>\n<h3><strong>Unither Pharmaceuticals&#8217; Acquisition of Carragelose\u00ae<\/strong><\/h3>\n<p>Unither Pharmaceuticals has incorporated Carragelose\u00ae into its ophthalmic product portfolio, reinforcing its expertise in drug delivery technologies. This acquisition aligns with Unither\u2019s broader commitment to advancing pharmaceutical innovations in ophthalmology, ensuring continued development and accessibility of Carragelose\u00ae formulations. Read more about this acquisition : <a href=\"https:\/\/www.unither-pharma.com\/marinomed-biotech-approves-sale\/\">Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division Marinomed Biotech AG: approves sale of Carragelose division<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Download the Whitepaper Discover a New Approach to Dry Eye Relief Dry Eye Disease (DED) affects millions of people worldwide, often leading to discomfort, blurred vision, and reduced quality of life. If you&#8217;re looking for innovative, preservative-free solutions that go beyond traditional eye drops, this whitepaper could be of real value. This whitepaper presents an [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":21269,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[92],"tags":[],"class_list":["post-26854","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/posts\/26854","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/comments?post=26854"}],"version-history":[{"count":1,"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/posts\/26854\/revisions"}],"predecessor-version":[{"id":26855,"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/posts\/26854\/revisions\/26855"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/media\/21269"}],"wp:attachment":[{"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/media?parent=26854"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/categories?post=26854"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dev8.id-interactive.fr\/new_unither\/wp-json\/wp\/v2\/tags?post=26854"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}